Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance

Even though the number of effective anti-tuberculosis or anti-mycobacterial agents is increasing, a large number of patients experience severe side effects as a result of these drugs. This hurts the patients’ well-being and quality of life. Tumor cells that survive treatment modalities can become ch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current microbiology Jg. 81; H. 10; S. 326
Hauptverfasser:	Mobed, Ahmad, Alivirdiloo, Vahid, Gholami, Sarah, Moshari, Amirreza, Mousavizade, Azamsadat, Naderian, Ramtin, Ghazi, Farhood
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Springer US 01.10.2024 Springer Nature B.V
Schlagworte:	Animals antibiotic resistance Antimicrobial resistance Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Biomedical and Life Sciences Biotechnology Chemotherapy Drug delivery Drug Delivery Systems - methods Drug resistance Drug Resistance, Bacterial Drugs Humans Life Sciences Microbiology Mycobacterium tuberculosis - drug effects nanomedicine Nanomedicine - methods Nanoparticles Nanoparticles - chemistry neoplasms Quality of life Review Side effects Topical application Tuberculosis Tuberculosis - drug therapy Tuberculosis - microbiology Tumor cells Well being
ISSN:	0343-8651, 1432-0991, 1432-0991
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!